Diseases And Disorders In The United States

"UDN Grand Rounds are open to the public. Presentations from UDN sites and cores describe the clinical phenotype and multidisciplinary, personalized diagnostic evaluation of one or more UDN participants. Students, trainees, advocates, and others are welcome to attend, ask questions, and offer insights on cases. CME credits are available at no charge for attendees."

"Diagnosis at the edges of our knowledge calls upon clinicians to be data driven, cross-disciplinary, and collaborative in unprecedented ways. Exact disease recognition, an element of the concept of precision in medicine, requires new infrastructure that spans geography, institutional boundaries, and the divide between clinical care and research. The National Institutes of Health (NIH) Common Fund supports the Undiagnosed Diseases Network (UDN) as an exemplar of this model of precise diagnosis. Its goals are to forge a strategy to accelerate the diagnosis of rare or previously unrecognized diseases, to improve recommendations for clinical management, and to advance research, especially into disease mechanisms. The network will achieve these objectives by evaluating patients with undiagnosed diseases, fostering a breadth of expert collaborations, determining best practices for translating the strategy into medical centers nationwide, and sharing findings, data, specimens, and approaches with the scientific and medical communities. Building the UDN has already brought insights to human and medical geneticists."

"Approximately 25–30 million individuals in the United States are living with a rare disease. ... Many children with rare diseases remain undiagnosed throughout life, leading to excess medical care, expensive diagnostic odysseys, and frustration for patients and their families. ... Advances in genomic technology have allowed for more comprehensive genetic analyses of patients with rare diseases. In an effort to better characterize patients with rare and undiagnosed diseases, the National Institutes of Health launched a single-site project, the Undiagnosed Diseases Program, to improve our understanding of the etiology of these disorders. Following initial success, the program expanded to encompass additional clinical and research institutions, thus establishing the Undiagnosed Diseases Network. ... The UDN is a network of investigators across 13 institutions designated to serve public need by bringing expertise in clinical diagnostics, translational research, and multi-omics technologies to solve medical mysteries ..."

"Undiagnosed diseases are defined as constellations of findings that remain refractory to medical diagnostic approaches. Undiagnosed diseases affect approximately 30 million Americans and include (a) rare diseases that are difficult to identify, (b) atypical presentations of known disorders, and (c) yet to be described diseases ... Undiagnosed diseases typically manifest with objective findings, which are clinically measurable on physical examination or through medical testing and these provide tangible targets for further diagnostic approaches (e.g. dysmorphic facies, abnormal biochemical profiles, physical exam demonstrating weakness or abnormal gait). Approximately 80% of rare and undiagnosed disorders have a genetic basis ..."

"Attention-grabbing headlines claiming that opioids (or any other drug) are killing people are wrong. Ignorance and poverty are killing people, just as they have for centuries."

"As with previous “drug crises,” the opioid problem is not really about opioids. It’s mainly about cultural, social, and environmental factors such as racism, draconian drug laws, and diverting attention away from the real causes of crime and suffering."

"Heroin and other opioids, such as oxycodone and morphine, bring me pleasurable calmness, just as alcohol may function for the drinker subjected to uncomfortable social settings. Opioids are outstanding pleasure producers; I am now entering my fifth year as a regular heroin user. I do not have a drug-use problem. Never have. Each day, I meet my parental, personal, and professional responsibilities. I pay my taxes, serve as a volunteer in my community on a regular basis, and contribute to the global community as an informed and engaged citizen. I am better for my drug use."

"Our national opioid problem also affects the well-being of children in a striking fashion. According to the Centers for Disease Control and Prevention (CDC), between 2008 and 2012, a third of women in their childbearing years filled -based medication prescriptions in pharmacies and an estimated 14 percent–22 percent of them were pregnant. The result: an alarming increase in the number of babies exposed to opioids in utero and experiencing withdrawal symptoms at birth, which is also known as neonatal abstinence syndrome, or NAS, in medical lingo. [...] (Given the ongoing opioid crisis, it’s unlikely that things have improved in recent years.) And the complications attributable to NAS don’t stop with birth. Though the research remains at an early stage—the opioid crisis only began in the early 1990s—it suggests that the ill effects of NAS extend well beyond infancy and include impaired cognitive and s, respiratory ailments, , difficulty maintaining intellectual focus, and behavioral traits that make productive with others harder. At this point, you won’t be surprised to learn that NAS and child poverty are connected. Prescription opioid use rates are much higher for women on , who are more likely to be poor than those with private insurance. Moreover, the abuse of, and overdose deaths from, opioids (whether obtained through prescriptions or illegally) have been far more widespread among the poor."